James Chambers to Prognosis
This is a "connection" page, showing publications James Chambers has written about Prognosis.
Connection Strength
0.216
-
Nakashima K, Matsumoto I, Goto-Koshino Y, Hiyoshi-Kanemoto S, Kojima K, Chambers JK, Takeuchi Y, Tsujimoto H, Tomiyasu H, Uchida K. Prognostic value of increased intraepithelial lymphocytes and lymphocytic clonality in dogs with chronic enteropathy or small-cell lymphoma. Vet J. 2023 Jun-Jul; 296-297:105993.
Score: 0.041
-
Ii T, Chambers JK, Nakashima K, Goto-Koshino Y, Mizuno T, Uchida K. Intraepithelial cytotoxic lymphocytes are associated with a poor prognosis in feline intestinal T-cell lymphoma. Vet Pathol. 2022 11; 59(6):931-939.
Score: 0.039
-
Schulman FY, Roccabianca P, Avallone G, Bertram CA, Chalkley M, Chambers JK, Donovan TA, Foster RA, Meuten D, Porcellato I, Priestnall SL, Rasotto R, Uchida K, Webster JD, Wood GA, Caswell JL. Reporting guidelines for manuscripts on tumor prognosis. Vet Pathol. 2022 05; 59(3):397-398.
Score: 0.038
-
Itoh T, Kojimoto A, Uchida K, Chambers J, Shii H. Long-term postsurgical outcomes of mast cell tumors resected with a margin proportional to the tumor diameter in 23 dogs. J Vet Med Sci. 2021 Feb 25; 83(2):230-233.
Score: 0.035
-
Eto S, Saeki K, Yoshitake R, Yoshimoto S, Shinada M, Ikeda N, Kamoto S, Tanaka Y, Kato D, Maeda S, Tsuboi M, Chambers J, Uchida K, Nishimura R, Nakagawa T. Anti-tumor effects of the histone deacetylase inhibitor vorinostat on canine urothelial carcinoma cells. PLoS One. 2019; 14(6):e0218382.
Score: 0.032
-
Tsuboi M, Sakai K, Maeda S, Chambers JK, Yonezawa T, Matsuki N, Uchida K, Nakayama H. Assessment of HER2 Expression in Canine Urothelial Carcinoma of the Urinary Bladder. Vet Pathol. 2019 05; 56(3):369-376.
Score: 0.031